New anti-epileptic drugs in the 1990s.
Buchanan
N
N
Department of Paediatrics, Westmead Hospital, Sydney, Australia.
D000085:Acetates / Q000627:therapeutic use; D000588:Amines; D014151:Anti-Anxiety Agents; D000927:Anticonvulsants / Q000627:therapeutic use*; D001569:Benzodiazepines; D001570:Benzodiazepinones / Q000627:therapeutic use; D000078306:Clobazam; D003509:Cyclohexanecarboxylic Acids; D015507:Drugs, Investigational / Q000627:therapeutic use*; D004827:Epilepsy / Q000188:drug therapy*; D000078328:Felbamate; D000077206:Gabapentin; D006801:Humans; D000077213:Lamotrigine; D048448:Phenylcarbamates; D011409:Propylene Glycols / Q000627:therapeutic use; D014227:Triazines / Q000627:therapeutic use; D020888:Vigabatrin; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives / Q000627:therapeutic use
D000085:Acetates; D000588:Amines; D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D001570:Benzodiazepinones; D003509:Cyclohexanecarboxylic Acids; D015507:Drugs, Investigational; D048448:Phenylcarbamates; D011409:Propylene Glycols; D014227:Triazines; D001569:Benzodiazepines; D000078306:Clobazam; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D020888:Vigabatrin; D000077213:Lamotrigine; D000078328:Felbamate